Jump to main content Jump to sidebar

blurb.social: Discover the web

Forums

Log in
Sign up

Overview
Submissions
Comments

modernatxcom6134

Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company's Next Generation COVID-19 Vaccine - Moderna Investor Relations

investors.modernatx.com

Submitted by modernatxcom6134 on June 16, 2024 at 12:28 AM in health

No comments

14

Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R) - Moderna Investor Relations

investors.modernatx.com

Submitted by modernatxcom6134 on June 2, 2024 at 12:14 AM in news

No comments

60

Moderna And Merck Announce mRNA-4157 (V940) In Combination with Keytruda(R) (Pembrolizumab) Demonstrated Continued Improvement in Recurrence-Free Survival and Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma - Moderna Investor Relations

investors.modernatx.com

Submitted by modernatxcom6134 on December 15, 2023 at 11:34 AM in news

No comments

34

modernatxcom6134

Registered on September 14, 2023

We love you.